Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2015). Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters, 357(1), 160. https://doi.org/10.1016/j.canlet.2014.11.020
Chicago Style (17th ed.) CitationLiapis, Vasilios, et al. "Hypoxia-activated Pro-drug TH-302 Exhibits Potent Tumor Suppressive Activity and Cooperates with Chemotherapy Against Osteosarcoma." Cancer Letters 357, no. 1 (2015): 160. https://doi.org/10.1016/j.canlet.2014.11.020.
MLA (9th ed.) CitationLiapis, Vasilios, et al. "Hypoxia-activated Pro-drug TH-302 Exhibits Potent Tumor Suppressive Activity and Cooperates with Chemotherapy Against Osteosarcoma." Cancer Letters, vol. 357, no. 1, 2015, p. 160, https://doi.org/10.1016/j.canlet.2014.11.020.